-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
Trial of doctor accused of poisoning 30 patients begins in France
A French doctor accused of intentionally poisoning 30 child and adult patients, 12 of whom died, went on trial Monday, saying before the hearing he was not responsible for the "distress" of his alleged victims and their families.
Frederic Pechier, 53, worked as an anaesthetist at two clinics in the eastern city of Besancon when patients went into cardiac arrest in suspicious circumstances between 2008 to 2017. Twelve could not be resuscitated.
He is accused of triggering heart attacks in patients so he could show off his resuscitation skills and discredit co-workers.
Pechier's youngest alleged victim, a four-year-old identified as Teddy, survived two cardiac arrests during a routine tonsil operation in 2016. The doctor's oldest alleged victim was 89.
The trial caps an eight-year investigation that stunned the medical community. Pechier has denied the charges.
Pechier was greeted on his arrival at the court by several relatives, including one who shouted: "Come on, Fredo."
"It's necessary to lay all the cards on the table," Pechier told broadcaster RTL earlier Monday, adding that he had "strong arguments" in his defence.
Asked about the suffering of the families who will attend the trial, set to last until December, Pechier replied: "I understand it completely, but on the other hand, I am not responsible for their distress."
Pechier, a father of three, faces life imprisonment if convicted. He is not currently in custody but under judicial supervision, an alternative to pre-trial detention.
- 'Waited 17 years' -
Pechier has not practised medicine since 2017, even though in 2023, he was authorised to work provided he does not come into contact with patients.
"I've been waiting for this for 17 years," said Amandine Iehlen, whose 53-year-old father died of cardiac arrest during kidney surgery in 2008.
An autopsy revealed an overdose of lidocaine, a local anaesthetic.
Prosecutor Etienne Manteaux has said the case is "unprecedented in French legal history".
An investigation was opened in 2017 after suspicious cardiac arrests during operations on patients considered low-risk.
Pechier is suspected of tampering with his colleagues' paracetamol bags or anaesthesia pouches to create operating room emergencies where he could intervene to show off his resuscitating talents.
"What he is accused of is poisoning healthy patients in order to harm colleagues with whom he was in conflict," Manteaux said.
"Frederic Pechier was the first responder when cardiac arrest occurred," he added. "He always had a solution."
Pechier has blamed "medical errors" by his colleagues for most of the poisonings.
- 'Legal marathon' -
Some colleagues described Pechier as a "star anaesthetist", while others said he came across as arrogant and manipulative.
One co-worker claimed Pechier was "certain he was the best" and liked to "think of himself as Zorro".
Over the course of the inquiry, investigators examined more than 70 reports of "serious adverse events", medical jargon for unexpected complications or deaths among patients.
The cases of 30 patients who suffered cardiac arrest during surgery at the Saint-Vincent Clinic and the Franche-Comte Polyclinic made it to trial.
He has criticised the investigation. "What happened to the other cases? They were not retained because Pechier was not involved in them," he said.
His defence team will argue for acquittal.
"It's very easy to accuse people, it's harder to prove things," one of his lawyers, Randall Schwerdorffer, told reporters.
More than 150 civil parties will be represented at the trial.
For the first two weeks, the court will examine Pechier's most recent cases, those that aroused the investigators' suspicions and led to the anaesthetist being placed under investigation in 2017.
Afterwards each of the poisonings attributed to the doctor will be examined.
"It's going to be a legal marathon, but we're ready," Stephane Giuranna, a lawyer for several civil parties, told AFP.
"All roads lead to Pechier."
T.Perez--AT